Trademark Overview
On Thursday, May 1, 2025, a trademark application was filed for GLYCOBIDUO with the United States Patent and Trademark Office. The USPTO has given the GLYCOBIDUO trademark a serial number of 99166457. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, May 1, 2025. This trademark is owned by OBI PHARMA, INC.. The GLYCOBIDUO trademark is filed in the Pharmaceutical Products category with the following description:
Immunostimulants; Chemical reagents for medical or veterinary purposes; Enzymes for medical purposes; Vaccines; Hormones for medical purposes; Adjuvants for medical purposes; Ferments for pharmaceutical purposes; Enzyme preparations for medical purposes; Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Tumor suppressing agents; Pharmaceutical preparations for suppressing tumors; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations for use in chemotherapy; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer to be prevented or treated; Pharmaceutical preparations for the treatment and prevention of cancer to be treated; Preparations of microorga...
